ent considerations in down’s

Upload: hossam-haridy

Post on 01-Mar-2018

222 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/25/2019 ENT Considerations in Downs

    1/50

    ENTConsiderations

    in

    Downs

    SyndromePrasad

    John

    Thottam,

    DO

    PediatricOtolaryngologyFellow

    ChildrensHospitalofPittsburghofUPMC

  • 7/25/2019 ENT Considerations in Downs

    2/50

    Generalinformation/definitions/considerations

    Otologicmanifestations

    Airwayand

    sleep

    considerations

    Generalsurgicalandmanagementpearls

    Outline

  • 7/25/2019 ENT Considerations in Downs

    3/50

    Identifiedasasyndromein1886byJohnLandonDown

    Microgenia,macroglossia,epicanthalfolds,upslantingpalpebralfissures,shorterlimbs,singletransversepalmarcrease,poormuscletone,mentalretardationandlearningdisabilities

    OriginallydescribedasMongolianidiocyuntil1961Lancet

    publication

    changing

    name

    to

    Downs

    Syndrome

    Chromosomalabnormality/chromosome21trisomywasidentifiedin1959byJeromeLejeune

    History

  • 7/25/2019 ENT Considerations in Downs

    4/50

    Trisomy21(47chromosomes;3chrms 21)

    94%ofDowns

    Riskincreases

    with

    maternal

    age

    Robertsonian translocationinvolvingchrm 21

    34%ofcases

    Notassociated

    with

    maternal

    age

    Trisomy21Mosaicism

    12%ofcases

    Genetics

  • 7/25/2019 ENT Considerations in Downs

    5/50

  • 7/25/2019 ENT Considerations in Downs

    6/50

    Mostcommoncongenitalchromosomalabnormality

    1of700livebirth1

    Massivegainslifeexpectancyoverthepast40years

    Lifeexpectancyin1983 25years2

    Lifeexpectancyin2014 50to60years3

    Primaryreasoning

    congenital

    heart

    surgical

    advancement2,3

    >50%reportseeinganotolaryngologistregularly4

    Epidemiology

  • 7/25/2019 ENT Considerations in Downs

    7/50

    Anatomical

    Midface hypoplasia

    Shortenedpalate

    RelativeMacroglossia

    Narrowedoropharynxandnasopharynx

    Hypotonia

    Paranasalsinusabnormalities

    Systemic

    Immunologicdeficiency

    Ciliary dyskinesia

    Predisposition

    to

    ENT

    related

    Problems

  • 7/25/2019 ENT Considerations in Downs

    8/50

    Congenitalheartdisease

    Pulmonaryhypertension

    GERD

    Subglotticstenosis

    Cervicalinstability

    Comorbidities

  • 7/25/2019 ENT Considerations in Downs

    9/50

  • 7/25/2019 ENT Considerations in Downs

    10/50

    EACstenosis

    Highincidenceofotitismedia

    Highincidence

    of

    chronic

    ear

    disease

    Secondaryhearingloss

    Ossicularabnormalities

    Innerear

    dysplasia

    OtologicManifestation

  • 7/25/2019 ENT Considerations in Downs

    11/50

    Presentin4050%ofDSnewborns5

    Generallyresolvesvianaturalprogressionandnotan

    obstacleby

    23

    years

    of

    age5

    Importantbecause:PCPexamination/infectionandhearingmonitoring

    Recommendation:Followupevery3monthsformicroscopicevaluation5

    Stenotic ExternalCanals

  • 7/25/2019 ENT Considerations in Downs

    12/50

    Reducedimmunesystem:T&Bcellreduction;IgG4reduction;defectiveneutrophilchemotaxis6,7

    Midface hypoplasia=

    narrowed

    ET

    and

    nasopharynx

    Adenoidtissueencroachment

    ETcartilagecollapseanddecreasedtensorveli

    palatini function Mastoidaeration

    Possiblehistopathologic changesofMEmucosa

    OtitisMedia/

    Chronic

    Ear

    Disease

  • 7/25/2019 ENT Considerations in Downs

    13/50

  • 7/25/2019 ENT Considerations in Downs

    14/50

    CongenitalanomaliesoftheETinDS:Histopathology9

    DSETsmaller,collapsedinmidcartilaginous,isthmusandpoorlydevelopedlateralcartilage

    TemporalbonemorphometricstudyonET&assoc.structuresinpatientswithchromosomalaberrations10

    Chromosomalaberration

    patients

    had

    smaller

    volume

    of

    lateral

    laminacartilage,reducedtensorveli palatini m.attachment

    Chrom.aberrationpatientsreducedLLtoMLratio

    EustachianTube

  • 7/25/2019 ENT Considerations in Downs

    15/50

    Examinedpatientsundergoingtympanoplasty DS&

    Non

    DS

    for

    history

    of

    COM Otorrhea 60%ofDSvs 27.2%NonDS(p

  • 7/25/2019 ENT Considerations in Downs

    16/50

    Animalmodel

    Ts65Dnmice

    (TrisomyChrm >80%

    homologous

    with

    Human

    21)

    comparedtowildtype

    ABRs/HistologicalexamofME/BacterialCultures

    Results ABRrequiredhighermeanthresholdinTs65Dnduetoeffusions

    Ts65Dnmicedemonstratedhigherdensityofgobletcells

  • 7/25/2019 ENT Considerations in Downs

    17/50

  • 7/25/2019 ENT Considerations in Downs

    18/50

    HigherprevalenceofhearinglossinDSregardlessofCHL/Mixed/SNHL12

    Estimated5090%ofDSchildrendxwithhearingimpairmentvs 49%generalpopulation12,13

    Monitoringisparamountashearinglosscanbedismissedasnaturalcourse/intellectualimpairment

    HearingLoss

  • 7/25/2019 ENT Considerations in Downs

    19/50

    Designedasstudytoexamineneedforamplificationin

    specializedschools

    92DSchildrenwithmild moderateintellectualimpairmentenrolledinspecialneedschools

    Perceivedhearingimpairmentasked

    Otologicexam;

    Tympanogram;

    TEOAEs;

    PTA

    conducted

    90%ofparticipantshadatleast>25dBHLinoneear

    19.1%hadTypeBtympanogram inatleastoneear

  • 7/25/2019 ENT Considerations in Downs

    20/50

  • 7/25/2019 ENT Considerations in Downs

    21/50

    HearinglossismaskedbyvariousdelaysseeninDS(speech;intellectual)14

    Earlydetection

    and

    associated

    maintenance

    critical

    Effectofhearinglossisgreateronchildrenwithdevelopmentaldelaycomparedtonondelayed(critical)14

    HearingLoss

  • 7/25/2019 ENT Considerations in Downs

    22/50

    ABR/OAEscreeningatbirth

    Hearingscreeningevery6monthsuptoage3depending

    if

    ear

    specific

    behavior

    audiometry

    can

    be

    establishedandisnormal

    Onceearspecificaudiometryestablished testing

    performedannually

  • 7/25/2019 ENT Considerations in Downs

    23/50

    Surprisinglycontroversial

    Shorttermefficacyoftympanostomy tubesforsecretoryOMin

    childrenwith

    DS15

    24DSvs 21nonDS/AllwithsecretoryOMandCHL/Agematched

    Audiogramperformed69wks postBMT

    60%of

    DS

    vs 91%

    in

    non

    DS

    reported

    improvement

    NOTE:allpatientsovertheageof6>delayoftreatment

    Tympanostomy Tubes

  • 7/25/2019 ENT Considerations in Downs

    24/50

    ProspectivestudyexaminingDS/OME/BMTovertime

    Allenrolledundertheageof2with81%CHL

    Followedby

    ENT

    every

    3

    6

    months

    TreatedwithBMTandreplacements

    At2years93%hadnormalhearing

    Aggressivemanagement

    of

    DS

    OME

    =

    3.6xs

    higher

    rate

    of

    normalhearingcomparedtoagematchednonaggressivetreatment

  • 7/25/2019 ENT Considerations in Downs

    25/50

    Agerequiring

    first

    set

    of

    tubes

  • 7/25/2019 ENT Considerations in Downs

    26/50

    RelationshipofotitismediaandlanguageimpairmentinadolescentswithDS14

    Examinedlanguage

    scores

    in

    DS

    adolescents

    now

    with

    normal

    hearing

    KidswithhistoryoftubeshadhigherlanguagescoresthanDSwithnotubeswhohad>3knownchildhoodinfxns

    Conclusion

    Temporaryhearinglossmayplayroleinlanguagedeficits

    Hearinglosseffectscanbepresentlongafterdiseasecourse

    Tympanostomy Tubes&DSConsiderations

  • 7/25/2019 ENT Considerations in Downs

    27/50

    TubesmaybeplacedearlyinchildrenwithDS

    Expectchildtorequiremultiplesets

    Needcloser

    monitoring

    and

    audiology

    visits

    Risks:

    Otorrhea,persistentperforation,cholesteatoma

    TubereinsertionshouldbecounseledasacontinuationoftreatmentNOTafailureoftreatment

    Factsfor

    parents

    tubes

    in

    DS

  • 7/25/2019 ENT Considerations in Downs

    28/50

    Estimatedashighas80%inDSvs 12%nonsyndromic15,16

    Manypredisposingfactorsthatcontribute

    Singlemodality

    treatment

    often

    not

    curative

    Canleadtofurtherneurocognitivedelayinthealreadydelayed

    Pulmonary

    HTN

    in

    children

    predisposed

    to

    cardiac

    anomalies

    ObstructiveSleep

    Apnea

  • 7/25/2019 ENT Considerations in Downs

    29/50

    Midfacial andmandibularhypoplasia

    Relativemacroglossia

    Glossoptosis Smallerupperairwaypronetoadenotonsillarencroachment

    Lingualtonsilhypertrophy

    Laryngomalacia

    Increasedsecretions

    Increasedobesity

    Generalizedhypotonia

    PredisposingFactors

  • 7/25/2019 ENT Considerations in Downs

    30/50

  • 7/25/2019 ENT Considerations in Downs

    31/50

    Prospective;agematched;4groupstudydesign

    FacialanalysisofDStoSiblingstobothagematchedsamples(n=55ineachgroup)

    Examinedfacialpointsforfluctuatingasymmetry(FA)betweenallgroups

  • 7/25/2019 ENT Considerations in Downs

    32/50

    Conclusions:

    DSsamplehadfluctuatingfacialasymmetrywhencomparedto

    othergroups

    Whencomparedtosiblings,DShad2.7to6.9foldnumberofsignificantdifferencesinfacialfeatures/regions

    Frontalprominencewasmoststable

    Mandibularprominence

    most

    unstable/

    underdeveloped

    followed

    bymaxillaryprominence

  • 7/25/2019 ENT Considerations in Downs

    33/50

    ExamineifDSpatientshavetruemacroglossia

    16DScomparedtoagematchednonDSpatients

    All

    O

    AHI>

    5

    MRIexaminedtonguesize&bonyconfines

    Conclusion

    DStonguesmaller thancontrol(p=0.02)

    DSbonyconfinessmaller thancontrol(p

  • 7/25/2019 ENT Considerations in Downs

    34/50

  • 7/25/2019 ENT Considerations in Downs

    35/50

    Thoughttobesecondarynarrowingofnasopharynxandoropharynx

    Contributionby

    relative

    hypotonia

    Adenotonsillectomyonlycurative27%ofDSpatients17

    OngoingCHPstudyonTA,PSGandDS(Thottam,Choi,Kitsko)

    CSAdecreasepostTA(p=0.02)

    88%reductionindiseaseseverity(p

  • 7/25/2019 ENT Considerations in Downs

    36/50

    Retrospectivecasecontrolstudylateralxray

    Examinedlingualtonsillar sizeinpatients(105DS&89nonDS)

    Lingualtonsillar sizewassignificantlylargerinDS(p=0.0008)

    Lingualtonsillar sizecorrelatedwithincreasingageinDS

    (p

  • 7/25/2019 ENT Considerations in Downs

    37/50

    ExaminedDS&agecontrolnonDSpatientswithoutOSA

    UnderwentMRIevaluationsofairwayvolume&measurements

    Conclusion

    AirwayvolumeinDS18%smaller/16%oropharynx

    Smallerbony

    parameters

    (mid

    lower

    face)

    DSwithoutOSAhadsmallertonsil&adenoidscomparedtocontrols&similarBOTandparapharyngeal softtissue

    Likely

    soft

    tissue

    crowding

    at

    sites

    causing

    OSA

  • 7/25/2019 ENT Considerations in Downs

    38/50

    So,whoneedstobeevaluatedandwhen?

  • 7/25/2019 ENT Considerations in Downs

    39/50

    DSunderwentovernightPSGsafterexam&questions

    ParentalquestionnairesonOSAsigns/symptoms,physicalandhistory

    Results

    69%(24/35)parentsreportednosleepproblemsBUT 54%(13/24)ofthisgroupdemonstratedOSAonPSG

    60%of

    kids

    with

    negative

    histories

    had

    abnormal

    PSGs

    Concluded:AllDSchildrenbetweenages34yearsofageshould

    getovernight

    baseline

    PSG

    to

    have

    objective

    data

  • 7/25/2019 ENT Considerations in Downs

    40/50

    HASTOBEOVERNIGHTSTUDY

    Napstudies

    tend

    to

    underestimate

    severity18

    Napstudieshavedemonstratedlesssensitivity(75%)ofpatientswithOSA;comparedtofullnight(100%)inpreviousstudy18

    Sowhat

    kind

    of

    study?

  • 7/25/2019 ENT Considerations in Downs

    41/50

    CLINICALPRACTICE

    GUIDELINE19

    AllchildrenwithDSgetPSGbeforeundergoingTA

    Parentsjust

    dont

    understand

    its

    under

    reported

    Givethemobjectiveevidence

    May

    require

    more

    than

    just

    a

    TA

    Canfollowresultsandprogression(baseline)

    SOwhy

    get

    a

    PSG

    in

    DS

  • 7/25/2019 ENT Considerations in Downs

    42/50

    Adenotonsillectomyaloneinitially

    Nodatatosupportmoreaggressivesurgeryinitially20

    TA+lateral pharyngoplasty vs TAalone20

    1. Nostatistical

    difference

    in

    OSA

    post

    operatively

    with

    roughly5060%bothhavingresidualOSA

    Nextplacetolook>BOT/lingualtonsils

    Genioglossus advancement+BOTcoblation postTA21

    1. 63%ofDSpatientsAHI

  • 7/25/2019 ENT Considerations in Downs

    43/50

    PSGneeded

    before

    surgery

    TAoftennotcurativesooftensetrealisticgoals

    25%cureratebutamuchhigherreductionrate22

    ReduceCPAPsettings/increasecompliance

    IfobeseBMIreductionalwayshelps

    Increasedriskandhavetostayovernight23,24

    Longerhospitalstay;decreasedPO;5xsincreaseinrespiratoryevent

    Increasedrisk

    of

    VPI

    and

    hypernasal speech24,25

    Higharchedpalate,hypotonia,Levator dysfunction

    Moresurgery/furtherinterventionsandPSGsarecommon

    PointsforParentsonOSA/DS/Surgery

  • 7/25/2019 ENT Considerations in Downs

    44/50

    SubglotticStenosis

    Atlantoaxialinstability

    (def)increasedmobilityatthearticulationofthefirst&secondcervicalvertebrae

    Duetogeneralizedligamentouslaxityofanyoforallthe3

    ligamentsof

    the

    C1

    C2

    joint

    GeneralOperative

    Consideration

  • 7/25/2019 ENT Considerations in Downs

    45/50

    SubglotticStenosisandDS26

    4%ofDSpopulationrequiredLTRSvs.0.15%ofnonDS

    Secondaryto

    congenital

    narrowing

    and

    acquired

    LTPforSGSinDS:TheCincinnatiExperience27

    Higherrateofintubation2ndarytocardiacsurgery

    Severerespiratoryinfectionsrequiringintubation

    Theaboveoccursatayoungage=increasedriskofSGS

    SubglotticStenosis

  • 7/25/2019 ENT Considerations in Downs

    46/50

    ProspectivelyevaluatedDSairwaysizeinDS(42)comparedtocontrol(32)

    Leak

    tests

    and

    MRIs

    (evaluate

    diameter)

    Concluded

    DSkidsrequiredETT23sizessmaller

    Recommended:ETTinDSbe2sizessmallerforintubationandcriticaltocheckforairleakat1030cmH20

  • 7/25/2019 ENT Considerations in Downs

    47/50

    Wasfirstbroughttowideattentionin1983SpecialOlympics

    Incidencereportedtobearound14%BUTonly1.5%27

    determinedtosymptomatic

    Catastrophicinjury

    can

    occur

    at

    extension

    and

    rotation

    BUT

    hasbeendemonstratedinpatientswithlongstandinghistoryofsigns(abnormalgait;limitedneckmobilityetc)28

    Recommendations:

    1. Historyofneurologicalsignsgreaterprioritythanradiography

    2. SupportheadwithrotationforBMTandlimitedextension

    AAInstability

    in

    DS

  • 7/25/2019 ENT Considerations in Downs

    48/50

    Forstenotic earcanalshearingandcerumen shouldbemonitoredclosely

    DSchildshouldundergobehavioralaudiologic testingq6

    monthsor

    q3

    if

    canals

    are

    stenotic until

    able

    to

    tolerate

    ear

    specifictesting

    TreatOMEaggressively&prepareformultipletubes

    HighrateofOSA&getPSGat34y/oregardless

    TAis

    first

    treatment

    but

    only

    25%

    successful

    Intubatewithtube2sizessmaller

    Carefulwhenturningheadandhistoryismostimportant

    Summary

  • 7/25/2019 ENT Considerations in Downs

    49/50

    ThankYou

  • 7/25/2019 ENT Considerations in Downs

    50/50